UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease

International journal of molecular sciences, 2022-06, Vol.23 (12), p.6371

2022

Volltextzugriff (PDF)

Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator

EMBO molecular medicine, 2018-11, Vol.10 (11), p.n/a

2018

Volltextzugriff (PDF)

Neurofilaments contribution in clinic: state of the art

Frontiers in aging neuroscience, 2022-11, Vol.14, p.1034684-1034684

2022

Volltextzugriff (PDF)

Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort

Alzheimer's research & therapy, 2022-07, Vol.14 (1), p.1-96, Article 96

2022

Volltextzugriff (PDF)

Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data

Alzheimer's research & therapy, 2022-01, Vol.14 (1), p.14-14, Article 14

2022

Volltextzugriff (PDF)

Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies

Alzheimer's research & therapy, 2024-07, Vol.16 (1), p.146-11, Article 146

2024

Volltextzugriff (PDF)

CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One

Frontiers in neurology, 2021-08, Vol.12, p.623777-623777

2021

Volltextzugriff (PDF)

Detection of histone acetylation levels in the dorsal hippocampus reveals early tagging on specific residues of H2B and H4 histones in response to learning

PloS one, 2013-03, Vol.8 (3), p.e57816-e57816

2013

Volltextzugriff (PDF)

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies

NeuroImage clinical, 2020-01, Vol.27, p.102333-102333, Article 102333

2020

Volltextzugriff (PDF)

Involvement of ApoE4 in dementia with Lewy bodies in the prodromal and demented stages: evaluation of the Strasbourg cohort

GeroScience, 2023-08, Vol.46 (2), p.1527-1542

2023

Volltextzugriff (PDF)

Biomarqueurs du liquide cérébrospinal dans la maladie à corps de Lewy

Revue francophone des laboratoires, 2021-07, Vol.2021 (534), p.28-37

Bousiges, Olivier

2021

Volltextzugriff (PDF)

Diagnostic value of cerebro-spinal fluid biomarkers in dementia with lewy bodies

Clinica chimica acta, 2019-03, Vol.490, p.222-228

2019

Volltextzugriff (PDF)

Transient epileptic amnesia: a retrospective cohort study of 127 cases, including CSF amyloid and tau features

Journal of neurology, 2023-04, Vol.270 (4), p.2256-2270

2023

Volltextzugriff (PDF)

Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?

Journal of Alzheimer's disease, 2016-05, Vol.52 (3), p.1125

2016

Volltextzugriff (PDF)

Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer's disease patients

European neuropsychopharmacology, 2020-04, Vol.33, p.101-116

2020

Volltextzugriff (PDF)

Valeur diagnostique des biomarqueurs Alzheimer du liquide cérébrospinal dans la maladie à corps de Lewy [Diagnostic value of Alzheimer's biomarkers in cerebrospinal fluid in dementia with Lewy body]

Gériatrie et psychologie neuropsychiatrie du vieillissement, 2018-06, Vol.16 (2), p.174-180

2018

Volltextzugriff (PDF)

A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice

The Journal of neuroscience, 2013-06, Vol.33 (26), p.10698-10712

2013

Volltextzugriff (PDF)

Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer's Disease: A Longitudinal Study

Journal of Alzheimer's disease, 2023-01, Vol.94 (1), p.147

2023

Volltextzugriff (PDF)

Neural correlates of photophobia in prodromal and mild dementia with Lewy bodies

European journal of neurology, 2023-08, Vol.30 (8), p.2215-2221

2023

Volltextzugriff (PDF)

Diagnostic value of CSF chromogranin A to discriminate between Alzheimer's disease and dementia with Lewy bodies

Neuropathology and applied neurobiology, 2024-02, Vol.50 (1), p.e12961-n/a

2024

Volltextzugriff (PDF)

Late-Life Environmental Enrichment Induces Acetylation Events and Nuclear Factor κB-Dependent Regulations in the Hippocampus of Aged Rats Showing Improved Plasticity and Learning

The Journal of neuroscience, 2016-04, Vol.36 (15), p.4351-4361

2016

Volltextzugriff (PDF)

Environmental exposure to phthalates and dementia with Lewy bodies: contribution of metabolomics

Journal of neurology, neurosurgery and psychiatry, 2020-09, Vol.91 (9), p.968

2020

Volltextzugriff (PDF)

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

Scientific reports, 2019-05, Vol.9 (1), p.7013, Article 7013

2019

Volltextzugriff (PDF)

Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice

Clinica chimica acta, 2019-08, Vol.495, p.451-456

2019

Volltextzugriff (PDF)

Acetyltransferases (HATs) as Targets for Neurological Therapeutics

Neurotherapeutics, 2013-10, Vol.10 (4), p.568-588

2013

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(46)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease

Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator

Neurofilaments contribution in clinic: state of the art

Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort

Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data

Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies

CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One

Detection of histone acetylation levels in the dorsal hippocampus reveals early tagging on specific residues of H2B and H4 histones in response to learning

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies

Involvement of ApoE4 in dementia with Lewy bodies in the prodromal and demented stages: evaluation of the Strasbourg cohort

Biomarqueurs du liquide cérébrospinal dans la maladie à corps de Lewy

Diagnostic value of cerebro-spinal fluid biomarkers in dementia with lewy bodies

Transient epileptic amnesia: a retrospective cohort study of 127 cases, including CSF amyloid and tau features

Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?

Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer's disease patients

Valeur diagnostique des biomarqueurs Alzheimer du liquide cérébrospinal dans la maladie à corps de Lewy [Diagnostic value of Alzheimer's biomarkers in cerebrospinal fluid in dementia with Lewy body]

A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice

Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer's Disease: A Longitudinal Study

Neural correlates of photophobia in prodromal and mild dementia with Lewy bodies

Diagnostic value of CSF chromogranin A to discriminate between Alzheimer's disease and dementia with Lewy bodies

Late-Life Environmental Enrichment Induces Acetylation Events and Nuclear Factor κB-Dependent Regulations in the Hippocampus of Aged Rats Showing Improved Plasticity and Learning

Environmental exposure to phthalates and dementia with Lewy bodies: contribution of metabolomics

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice

Acetyltransferases (HATs) as Targets for Neurological Therapeutics

Suchergebnisse filtern